Neoadjuvant Strategies for Triple Negative Breast Cancer: ‘State-of-the-art’ and Future Perspectives

E-ISSN： 1875-5992|15|1|15-25

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.15, Iss.1, 2015-01, pp. : 15-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2825-2832

Spandidos Publications

Access to resources Recommend Favorite

Polygenic susceptibility to breast cancer: current state-of-the-art

By Ghoussaini Maya Pharoah Paul DP

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 689-701

Future Medicine

Access to resources Recommend Favorite

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

By Masuda Hiroko Masuda Norikazu Kodama Yoshinori Ogawa Masami Karita Michiko Yamamura Jun Tsukuda Kazunori Doihara Hiroyoshi Miyoshi Shinichiro Mano Masayuki Nakamori Shoji Tsujinaka Toshimasa

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 911-917

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of neoadjuvant chemotherapy for triple-negative breast cancer: a meta-analysis with 723 cases

By Zhang Guojing Xie Wanqing Xu Long Liu Zhaozhe Xie Xiaodong

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 1, 2013-01 ,pp. : 15-19

Springer Publishing Company

Access to resources Recommend Favorite